The clinical results of SCO-267 was presented at the Virtual 81st Scientific Sessions - American Diabetes Association: First report on the clinical data of a GPR40 full agonist in the phase 1 trial
June 28, 2021
June 28, 2021
June 18, 2021
June 15, 2021
June 1, 2021
May 27, 2021
May 6, 2021
May 5, 2021
March 29, 2021
March 25, 2021
December 4, 2025
The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
October 29, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible EazeBio today announced a ...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225